Summary Short chain fatty acids (SCFAs) are produced in the colonic lumen mainly by bacterial fermentation of dietary fiber. Emerging evidence shows that SCFA has important physiological and pathophysiological effects on colonic and systemic events. Recently, propionate, known as a kind of SCFA, has been shown to lower fatty acid contents in plasma and reduce food intake. However, the detailed mechanism underlying the propionate-mediated lipid metabolism action remains poorly understood. The intestinal lipid metabolism process is critical for systemic energy homeostasis. Therefore, we investigate here the effects of propionate on intestinal lipid metabolism. Results show that propionate induced peroxisome proliferator-activated receptor a (PPARa) expression time-dependently and concentrationdependently in YAMC (a mouse intestinal epithelial cell line) cells. The expression levels of PPARa-responsive genes such as carnitine palmitoyl transferase II (CPTII) and trifunctional protein a (TFPa) were up-regulated in the presence of propionate, thereby suppressing triglyceride (TG) accumulation. Furthermore, propionate-mediated PPARa induction required phosphorylation of extracellular signal-regulated kinase. Collectively, these data indicate that propionate regulates intestinal lipid metabolism through the induction of PPARa expression. Results suggest that the inhibitory effect of propionate on TG accumulation partly contributes to the propionate-mediated fatty acid-lowering effect.
Short chain fatty acids (SCFAs), including acetic acid, propionic acid, and butyric acid, are produced in the colonic lumen mainly by bacterial fermentation of dietary fiber and resistant starch (1) . Emerging evidence indicates that SCFAs have very important physiological effects on the colonic mucosa, including stimulation of mucous secretion, increase of motility, and sodium and water absorption (2) . Additionally, SCFAs can regulate systemic physiological and pathophysiological events such as regulation of the sympathetic nervous system and differentiation of immune cells (3) (4) (5) . However, most studies of the influence of SCFAs on mammalian physiology concentrate either solely on the role of butyric acid, or on the effects of SCFA mixtures. The potential effects of propionate on physiological and pathophysiological events have been underestimated (6) . Reportedly, propionate lowers fatty acids content in plasma and reduces food intake (7) (8) (9) (10) . However, the detailed mechanisms underlying the propionate-mediated lipid metabolism action remain poorly defined.
Dietary triglyceride (TG) is hydrolyzed into free fatty acids in the intestinal lumen. Then they are taken up by intestinal epithelial cells from their apical side, transported to the endoplasmic reticulum, and resynthesized into TG. This resultant TG is assembled into chylomicrons and transported into the bloodstream. This intestinal TG metabolism process is critical for systemic energy homeostasis (11, 12) .
The peroxisome proliferator-activated receptor (PPAR) is a ligand-activated transcriptional factor that exerts strong effects on metabolic pathways including lipid metabolism. PPAR forms a heterodimeric complex with retinoid X receptors. The resultant complex binds to PPAR response elements in the promoter regions of specific target genes, resulting in the up-regulation of their expressions. In general, the PPAR subfamily comprises three distinct members: PPARa, PPARd, and PPARg (13) . One of them, PPARa, is highly expressed by brown adipose tissue, liver, kidney, heart, and skeletal muscle. Emerging evidence indicates that PPARa is also expressed in the digestive tract and engages in several physiological events such as intestinal permeability and immune response (14) (15) (16) (17) . However, no evidence related to the exact biological role of PPARa exists in the intestinal lipid metabolism. Consequently, for this study, we investigated the effect of propionate on intestinal lipid metabolism, particularly in relation to PPARa expression in intestinal epithelial cells, which have always been connected with many bacterial metabolites including SCFA.
Materials and Methods
Cell culture. The Young Adult Mouse Colon (YAMC) cell line, used as mouse intestinal epithelial cells, was a generous gift from Dr. R. Whitehead (Vanderbilt University, Nashville, TN). This cell line is derived from the immortomouse, which express a temperature-sensitive SV40 large T antigen transgene under control of the INF-g-sensitive segment of the class MHC II promoter (18) . YAMC cells were cultured at the permissive temperature of 33˚C in RPMI1640 medium containing 5% fetal bovine serum, 5 U/mL murine IFN-g, 2 mm glutamine, and antibiotics (50 U/mL penicillin, 50 mg/mL streptomycin) and also supplemented with 6.25 mg/L insulin, 6.25 mg/L linoleic acid (ITS1Premix; Collaborative Biomedical Products Inc., Bedford, MA). Stock cultures were maintained at 33˚C and were split at a ratio of 1 : 6 every 4 d. Before all experiments, cells were cultured in IFN-g-free media under nonpermissive conditions at 37˚C for 24 h to destabilize the temperature-dependent SV40 large T antigen and to halt cell proliferation.
Quantitative real-time PCR. Total RNA was extracted from YAMC cells with Isogen (Nippon Gene Co. Ltd., Tokyo, Japan): it was then reverse-transcribed. The resultant cDNA was subjected to quantitative real-time PCR (qRT-PCR) using specific primers for PPARa (forward primer: 5′-CGATGCTGTCCTCCTTGATGA-3′, reverse primer: 5′-CGCGTGTGATAAAGCCATTG-3′), carnitine palmitoyl transferase II (CPTII) (forward primer: 5′-GGGCGAGCTTCAGCATATG-3′, reverse primer: 5′-GGCCCATCGCTGCTTCTT-3′), trifunctional protein a (TFPa) (forward primer: 5′-CCCCAAAGCCCGTTGTG-3′, reverse primer: 5′-GCATGCTATGGCAAGCTCAA-3′), and b-actin (forward primer: 5′-TATCCACCTTCCAG-CAGATGT-3′, reverse primer: 5′-AGCTCAGTAACAGTC-CGCCTA-3′). PCR was performed with a SYBR Green PCR Master Mix and a Real-Time PCR System (7300; Applied Biosystems, Foster City, CA). Relative quantification of gene expression with qRT-PCR data was calculated relative to b-actin. PCR conditions were denaturation at 95˚C for 15 s, and primer-annealing at 60˚C for 1 min, with subsequent melting curve analysis in which the temperature was increased from 60˚C to 95˚C.
Western blotting. YAMC cells cultured in the presence of propionate were harvested and lysed in CelLytic M Cell Lysis Reagent (Sigma-Aldrich Corp., St. Louis, MO). These lysates were centrifuged at 20,000 3g for 15 min. The supernatants were analyzed respectively using Western blot with a NuPAGE 10% Bis-Tris Gel and a NuPAGE Western transfer system according to the manufacturer's instructions (Invitrogen Corp., Carlsbad, CA) with rabbit polyclonal anti-PPARa (PA1-822A; Affinity Bioreagents Inc., Golden, CO), anti-extracellular signal-regulated kinase (ERK), anti-phospho-ERK, anti-JNK (c-jun N-terminal kinase), anti-phospho-JNK, antip38, anti-phospho-p38 (Cell Signaling Technology Inc., Beverly, MA) antibodies and goat polyclonal anti-b-actin (Ab8229; Abcam plc., Cambridge, MA) antibody, followed by immunoreaction with horseradish peroxidaseconjugated anti-rabbit and anti-goat IgG, respectively. The immunoreactive proteins were visualized with an ECL Plus Western Blotting Detection System (GE Healthcare, Piscataway, NJ).
Immunofluorescence staining. YAMC cells seeded on m-Dish 35 mm (ibidi GmbH, Munich, Germany) were cultured in the presence of propionate. Cells were fixed in 4% paraformaldehyde in PBS, followed by incubation with PBS containing 0.1% Triton X-100. Cells were incubated with Protein Block Serum-Free (Dako Corp., Carpenteria, CA) and were then incubated with rabbit polyclonal anti-PPARa antibody (PA1-822A). Cells were further incubated with Alexa Fluor 488-conjugated secondary anti-rabbit IgG (Invitrogen Corp.) and were labeled with Hoechst 33342 to stain nuclear chromatin, with subsequent inspection using a confocal laser scanning microscope.
Triglyceride measurements. YAMC cells cultured in the presence of 5 mm propionate for 24 h were harvested. Total TG content in the cells was determined using a TG assay kit (Wako Pure Chemical Industries, Ltd., Osaka, Japan). Assays were performed according to the manufacturer's instructions. After color development, optimal densities were measured at 600 nm using a plate reader (Spectramax M2; Molecular Devices Corp., Sunnyvale, CA).
Statistical analysis. Comparisons among three or more groups were performed using one-way analysis of variance (ANOVA) with Dunnett post hoc testing. Comparisons with two groups were performed using unpaired t-tests. Statistical analyses were conducted using statistical software (GraphPad Prism ver. 5.02; GraphPad Software Inc., San Diego, CA). All results are expressed as means6SE; differences for which p,0.05 were considered statistically significant.
Results
To investigate the effect of SCFA on PPARa gene expression in colonic epithelial cells, YAMC cells were cultured in the presence of several SCFAs. RT-PCR analysis showed that propionate, but not acetate, butyrate, or lactate, increased the PPARa mRNA level (Fig. 1A) . The increase in PPARa expression was time-dependent and concentration-dependent (Fig. 1B and C) . In association with the increase PPARa mRNA level, the expression of PPARa protein was increased in propionate-treated YAMC cells (Fig. 1D) . These results indicate that propionate up-regulates the expression levels of PPARa mRNA and protein in YAMC cells. Furthermore, to investigate the intracellular distribution of PPARa in YAMC cells cultured in the presence of propionate, we used immunofluorescence staining with confocal microscopy. Propionate induced the expression of PPARa remarkably. The expression was detected mainly in the nucleus (Fig.  1E) .
PPARa is a key regulatory factor of lipid metabolism. Therefore, we determined the effect of propionate on fatty acid b-oxidation in YAMC cells. Figure 2A shows that propionate induced the expressions of CPTII and TFPa, which are PPARa target genes. Additionally, a significant decrease in TG content was found in YAMC cells when treated with propionate (Fig. 2B) .
To characterize the molecular mechanism of PPARa induction by propionate further, YAMC cells cultured in the presence of propionate for the designated time periods. As presented in Fig. 3A , propionate treatment caused time-dependent phosphorylation of ERK. The ERK phosphorylation began at 15 min; then it decreased until 60 min after propionate treatment. The protein level of ERK was unaffected by propionate treatment. However, the phosphorylations of JNK and p38 kinase were unaffected. The inhibitor of ERK, U0126, suppressed the propionate-mediated induction of PPARa expression (Fig. 3B ).
Discussion
PPARa is expressed mainly in brown adipose and liver, but is also expressed in the intestine (14, 15) . The biology of PPARa in the intestine remains poorly defined, although lipid metabolism in the intestine profoundly affects systemic energy homeostasis (11, 12) . In this study, we demonstrated that propionate induced PPARa expression in colonic epithelial cells, and subsequently caused suppression of TG accumulation. Furthermore, we clarified that propionate induced PPARa expression in an ERK-dependent manner.
Evaluation of PPARa expression using qRT-PCR and Western blot analyses revealed that PPARa expression was up-regulated in YAMC cells in the presence of propionate. These results indicated that the expression of PPARa is up-regulated transcriptionally by propionate. On the other hand, acetate, butyrate, and lactate had no effect on PPARa expression, suggesting that the regulation of PPARa expression in colonic epithelial cells is most likely to be a propionate-specific function. Furthermore, previous reports showed that the physiological concentration of propionate in the lumen was about 20 mm (19, 20) , suggesting that the concentrations of propionate used in this study (1-10 mm) were the physiological condition.
Multiple protein kinase pathways including ERK kinase have been proposed to play a role in PPARa expression (21, 22) . We show here that propionate promoted the phosphorylation of ERK, but not of JNK or p38, and propionate-mediated induction of PPARa was suppressed by U0126, a specific inhibitor for ERK. Kimura et al. (3) reported that propionate induced sympathetic activation through the promotion of ERK phosphorylation in sympathetic neurons. Additionally, several SCFAs can potentiate the transcriptional activity of nuclear receptor through the activation of the ERK pathway (23) . These findings are consistent with our obtained data. However, the phosphorylation of ERK has been described as regulating PPARa expression in some reports, but not in others (3, 21, 22) . This discrepancy might reflect cell-specific and tissue-specific differences in the regulation of PPARa expression. These results suggest that although the role of the ERK pathway in the regulation of PPARa expression is controversial, propionate-mediated PPARa induction requires the ERK pathway.
PPARa plays a pivotal role in lipid metabolism. Our results showed that propionate prevented cellular TG accumulation in YAMC cells through the induction of PPARa expression. Evidence has been accumulating that propionate has fatty acid-lowering effects through the inhibition of fatty acid production in the liver (24) . Additionally, the decreases in fatty acid levels by propionate probably derive from the inhibition of lipolysis and the induction of adipogenesis in adipose tissue (25) . Our present results indicate that the augmentation of fatty acid b-oxidation in intestinal epithelial cells partly contributes to the propionate-mediated fatty acid-lowering effect.
In conclusion, our results reveal a novel scenario in which propionate up-regulates PPARa expression through the activation of the ERK pathway, and thereby decreases the intracellular TG accumulation in YAMC cells. This series of data not only identified the novel physiological function of propionate but also elucidated the biological role of PPARa in the intestine. Our data indicate that modulation of intestinal PPARa expression might maintain energy homeostasis to prevent obesity and its related diseases.
